SCHEMBL24523623

SCHEMBL24523623

c1ccc(-c2ccc(-c3ccc(-c4nc(-c5ccc(-c6ccc7ccccc7c6)cc5)nc(-c5ccc6c(c5)oc5cccc(-c7ccccc7)c56)n4)cc3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
TP53 P04637 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HSD17B10 Q99714 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP1A2 P05177 1/20 0.42
HSD17B1 P14061 2/20 0.40
HSD17B2 P37059 2/20 0.40
HCRTR1 O43613 2/20 0.38
PGR P06401 1/20 0.37
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
MAPT P10636 2/20 0.36
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24523245 1.00 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24523619 1.00 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24523632 1.00 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24523514 1.00 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL23821871 1.00 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24523267 1.00 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL23987427 1.00 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24523469 1.00 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24523346 1.00 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL26270994 1.00 ALDH1A1 (0.42) ALDH1A1KDM4ETP53SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220194956-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF Beijing Summer Sprout Technology Co., Ltd. (CN) 2022-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220194956-A1 ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF PIEZO1, LEF1, TMEM109 ALDH1A1 119/4885KDM4E 2399/4885TP53 4580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.